BioMarin Pharmaceutical Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Based on Analyst Price Targets
Vibrant Global Expansion And Innovative Therapies Set The Stage For Dynamic Growth
Key Takeaways BioMarin's strategic focus on new business units and geographic expansion is expected to enhance market penetration and revenue growth. Cost transformation initiatives aim to boost operating margins and profitability in tandem with expected robust revenue growth.
View narrativeUS$98.52
FV
35.6% undervalued intrinsic discount8.71%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
5 days ago author updated this narrative